News

Triangle background gray
Chris Beall Promoted to Partner at Martis Capital 448 486 Nina Leinman

Chris Beall Promoted to Partner at Martis Capital

Martis Capital Closes Oversubscribed Fourth Fund at $779 Million 448 486 Nina Leinman

Martis Capital Closes Oversubscribed Fourth Fund at $779 Million

Martis Capital Recognized for Contributions to Clinical Trials Market 150 150 Nina Leinman

Martis Capital Recognized for Contributions to Clinical Trials Market

Martis Capital Announces Recent Promotions 150 150 Nina Leinman

Martis Capital Announces Recent Promotions

Martis Capital and Lorient Capital Launch Rise Health 150 150 Nina Leinman

Martis Capital and Lorient Capital Launch Rise Health

Finding Attractive Investment Opportunities Across Target Themes 150 150 kari.sharp@gmail.com

Finding Attractive Investment Opportunities Across Target Themes

Martis Capital Named in Inc.’s 2022 List of Founder-Friendly Investors 150 150 kari.sharp@gmail.com

Martis Capital Named in Inc.’s 2022 List of Founder-Friendly Investors

Martis Capital Announces Investment in Alcanza Clinical Research 150 150 kari.sharp@gmail.com

Martis Capital Announces Investment in Alcanza Clinical Research

Martis Capital welcomes new Senior Associate and Associate to the investment team 150 150 kari.sharp@gmail.com

Martis Capital welcomes new Senior Associate and Associate to the investment team

Martis Capital recognized as a Top 50 PE firm in the Middle Market for 2022 448 486 kari.sharp@gmail.com

Martis Capital recognized as a Top 50 PE firm in the Middle Market for 2022